-
Mashup Score: 0How I diagnose and treat neonatal thrombocytopenia - 10 month(s) ago
Using illustrative cases, Stanworth and Mumford explore the current thinking about how best to diagnose and, when appropriate, treat thrombocytopenia in neonate
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 72023 Hematology Review Series - 10 month(s) ago
2023 Hematology Review Series
Source: academy.hematology.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Intermittent Dosing Strategy Helps Thrombocytopenia Related to MDM2 Inhibitor Milademetan - 12 month(s) ago
Milademetan, a MDM2 inhibitor, is associated with thrombocytopenia. An intermittent dosing schedule may help mitigate that adverse event.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Intermittent Dosing Strategy Helps Thrombocytopenia Related to MDM2 Inhibitor Milademetan - 1 year(s) ago
Milademetan, a MDM2 inhibitor, is associated with thrombocytopenia. An intermittent dosing schedule may help mitigate that adverse event.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Intermittent Dosing Strategy Helps Thrombocytopenia Related to MDM2 Inhibitor Milademetan - 1 year(s) ago
Milademetan, a MDM2 inhibitor, is associated with thrombocytopenia. An intermittent dosing schedule may help mitigate that adverse event.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
A novel machine-learning model has been developed to diagnose heparin-induced thrombocytopenia, which may reduce misdiagnosis.
Source: European Medical JournalCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Making a Diagnosis of Immune Thrombocytopenia - 1 year(s) ago
Opening their discussion on immune thrombocytopenia (ITP), expert panelists review criteria for diagnosis and highlight differences between adult and pediatric populations.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia - 1 year(s) ago
Karnes and colleagues report on the results of a genome-wide association study to find predictors of heparin-induced thrombocytopenia, comparing patients with a
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Thrombocytopenia: Evaluation and Management - 1 year(s) ago
Thrombocytopenia is a platelet count of less than 150 × 103 per μL and can occur from decreased platelet production, increased destruction, splenic sequestration, or dilution or clumping. Patients with a platelet count greater than 50 × 103 per μL are generally asymptomatic. Patients with platelet counts between 20 and 50 × 103 per μL may have mild skin manifestations such as petechiae, purpura,…
Source: www.aafp.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial - 1 year(s) ago
The antifibrinolytic agent tranexamic acid (TXA) is often used to prevent bleeding in patients with hemorrhagic disorders or platelet dysfunction, and there has
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
How I diagnose and treat #neonatal #thrombocytopenia 👉https://t.co/zZ7yydZNSF @BloodJournal @SimonStanworth #LifeThreatening https://t.co/p9nIIHynro